Company intelligence / Profile preview

Adragos Pharma

Munich, Bavaria, Germanyadragos-pharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Adragos Pharma provides end-to-end pharmaceutical development and manufacturing services globally. It specializes in small molecule finished dosage forms and offers capabilities for sterile/nonsterile liquids, solids, semi-solids, tablets, ampoules, and suppositories. The company operates state-of-the-art facilities in Europe and Japan with recent expansions increasing capacity for both solid oral dose forms and liquid filling lines. It adheres to global regulatory standards including FDA/EMA/PMDA compliance.

Modalities: Small moleculeBiologic (large molecule)Finished dosage forms (sterile and non-sterile liquids, solids, semi-solids)Biosimilars
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with pharmaceutical manufacturers/distributors globally

Beyond the preview

Go deeper on Adragos Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adragos Pharma.

Explore the full profile